Enliven Therapeutics (ELVN) Operating Income (2019 - 2026)
Enliven Therapeutics (ELVN) posted Operating Income of -$37.21 million for Q2 2026, compared with -$28.58 million a year earlier.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Operating Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Enliven Therapeutics was -$124.41 million; for FY2025, it was -$119.66 million.
- In prior years, Enliven Therapeutics' Operating Income was -$104.55 million in FY2024, -$83.53 million in FY2023, -$38.79 million in FY2022 and -$51.44 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Operating Income in data going back to Q1 2019.
- According to Business Quant data, Operating Income for the three prior quarters was -$27.82 million (Q1 2026), -$34.29 million (Q4 2025) and -$25.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - | -37.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.21 Mn |
| Mar 31, 2026 | -27.82 Mn |
| Dec 31, 2025 | -34.29 Mn |
| Sep 30, 2025 | -25.10 Mn |
| Jun 30, 2025 | -28.58 Mn |
| Mar 31, 2025 | -31.69 Mn |
| Dec 31, 2024 | -26.90 Mn |
| Sep 30, 2024 | -27.07 Mn |
| Jun 30, 2024 | -24.60 Mn |
| Mar 31, 2024 | -25.99 Mn |
| Dec 31, 2023 | -22.73 Mn |
| Sep 30, 2023 | -24.25 Mn |
| Jun 30, 2023 | -20.13 Mn |
| Mar 31, 2023 | -16.42 Mn |
| Dec 31, 2022 | -10.16 Mn |
| Sep 30, 2022 | -10.93 Mn |
| Jun 30, 2022 | -9.02 Mn |
| Mar 31, 2022 | -8.68 Mn |
| Dec 31, 2021 | -14.33 Mn |
| Sep 30, 2021 | -13.66 Mn |
API Access
Enliven Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();